Primos (Methenolone Enanthate)

About the Product

Primos is a research compound from Driada Medical, presented as a solution for intramuscular injection containing Methenolone Enanthate. Methenolone Enanthate is a synthetic anabolic androgenic steroid (AAS) derived from dihydrotestosterone (DHT), with a structural modification that enhances its anabolic properties while significantly reducing its androgenic potency. It is a DHT-derived compound with a methyl group at position 1 (1-methyl-DHT), which provides resistance to 5α-reductase and gives it a distinct pharmacological profile characterized by a favorable anabolic-to-androgenic ratio. The enanthate ester provides a long duration of action, allowing for sustained release in research protocols.

The product is intended for laboratory research use only and features an integrated QR code on the packaging for detailed product verification.

• Product Name: Primos (Methenolone Enanthate)

• Brand: Driada Medical

• Form: Injectable solution (oil-based)

• For Research Use Only.

Research Applications & Mechanism of Action

• DHT-Derived Anabolic: Methenolone is a derivative of dihydrotestosterone (DHT) with a methyl group at position 1 (1-methyl-DHT). These structural modifications result in:

  • Enhanced anabolic properties.

  • Significantly reduced androgenic potency compared to testosterone.

  • Resistance to 5α-reduction due to the 1-methyl group.

  • Non-aromatizable profile (DHT derivatives are not aromatized to estrogen).

  • A distinct receptor binding profile.

• Androgen Receptor Agonist: Methenolone Enanthate functions as an agonist at the androgen receptor (AR). Upon administration, the enanthate ester is cleaved by esterases, releasing active methenolone which binds to ARs in target tissues. This binding initiates a signaling cascade that regulates gene transcription via hormone response elements (HREs), mediating anabolic and androgenic effects.

• Long-Acting Ester Profile: The enanthate ester provides a long duration of action, offering researchers:

  • Sustained androgen receptor activation over an extended period.

  • Reduced dosing frequency in long-term studies.

  • More stable serum levels of the active compound.

• Non-Aromatizable Profile: Methenolone is not aromatized to estrogen, making it a valuable research tool for studying:

  • Pure anabolic effects without estrogenic complications.

  • Androgen receptor signaling in isolation from estrogen receptor activation.

  • Tissue-specific effects of androgens without estrogenic cross-talk.

• Resistance to 5α-Reduction: The 1-methyl group prevents 5α-reduction, providing researchers with a compound that:

  • Is not converted to a more potent metabolite.

  • Allows study of the parent compound's effects without metabolic conversion.

  • Provides a distinct profile compared to 5α-reducible androgens.

• Protein Anabolism: Methenolone promotes protein anabolism (building up of proteins) and reduces protein catabolism (breakdown), which can be studied in models of muscle physiology, metabolic research, and tissue repair.

• Metabolic Research: Studies can include investigating effects on:

  • Lipid metabolism and adipocyte function.

  • Glucose metabolism and insulin sensitivity.

  • Nitrogen retention and protein synthesis.

  • Bone metabolism and calcium homeostasis.

Research & Scientific Background

• Chemical Background: Methenolone (1-methyl-5α-androst-1-en-3β-ol-17-one) is a DHT derivative with a methyl group at position 1. The enanthate ester was developed to provide a long-acting formulation for research applications.

• Clinical Context: Methenolone Enanthate has been studied in clinical research contexts, particularly in relation to:

  • Treatment of muscle wasting conditions and cachexia.

  • Bone density research and osteoporosis.

  • Anabolic research with minimal androgenic effects.

  • Hormone replacement therapy research.

• Anabolic-to-Androgenic Ratio Research: Methenolone's favorable anabolic-to-androgenic ratio makes it a valuable tool for studying:

  • Separation of anabolic and androgenic effects.

  • Mechanisms of anabolic action.

  • Tissue-specific effects of androgens.

• Non-Aromatizable Androgen Research: As a non-aromatizable androgen, Methenolone Enanthate is a valuable tool for studying:

  • Androgen Receptor Signaling: Investigating the molecular mechanisms of androgen action without estrogenic cross-talk.

  • Pure Anabolic Effects: Understanding the anabolic effects of androgens in the absence of estrogenic activity.

  • Comparative Studies: Comparing effects with aromatizable compounds like testosterone.

• 5α-Reductase Research: Methenolone's resistance to 5α-reduction makes it a valuable tool for studying:

  • Role of 5α-reductase in androgen action.

  • Tissue-specific effects of non-5α-reduced androgens.

  • Comparative effects of 5α-reduced and non-5α-reduced compounds.

• Muscle Physiology Research:

  • Skeletal Muscle Studies: Investigating the effects of methenolone on muscle protein synthesis, satellite cell activation, and muscle fiber type composition.

  • Myogenic Differentiation: Studying the role of androgens in muscle cell differentiation and development.

  • Muscle Wasting Models: Investigating the potential for counteracting cachexia and sarcopenia.

• Bone Metabolism Research:

  • Osteoblast Studies: Investigating the effects on bone formation and mineralization.

  • Osteoporosis Research: Studying the potential benefits in bone density maintenance.

• Metabolic Research:

  • Adipose Tissue: Investigating the effects of methenolone on adipocyte metabolism and lipolysis.

  • Lipid Profiles: Studying the impact on cholesterol and lipid metabolism.

  • Insulin Sensitivity: Investigating effects on glucose homeostasis.

• Endocrinology Research:

  • Hypothalamic-Pituitary-Gonadal Axis: Studying the suppression of gonadotropins and the feedback mechanisms of androgens.

  • Hormonal Regulation: Investigating the interplay between methenolone and other hormones.

• Comparative Androgen Research: Methenolone is often used in comparative studies with testosterone, DHT, and other androgens to understand:

  • Structure-activity relationships of androgen receptor ligands.

  • Effects of 1-methylation on androgen activity.

  • Ester-specific effects on pharmacokinetics.